2009
DOI: 10.1211/002235709788610417
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
17
0
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(21 citation statements)
references
References 0 publications
2
17
0
2
Order By: Relevance
“…This batch of (Mo) was selected and validated based on previous pharmacological and chemical studies using batches from four common suppliers (Baldwins (London, UK), Pranarom (Lille, France), Quinessence (Coalville, UK), Fytosan (Die, France); the composition correlates with the natural products Herbal Pharmacopoeia standards and was confirmed to be stable throughout the research programme (Dr Melanie-Jayne Howes, Jodrell Laboratory, Kew Gardens). Furthermore, a batch was selected and used in a parallel clinical trial in late-stage of Alzheimer's disease patients [18,19]. The GC-MS profile carried out at the Royal Botanic Garden at Kew (London), displayed no major changes in (Mo) composition following long-term storage (18 months) at 4°C in the dark (composition reported previously in [18,19]).…”
Section: Chemicals and Herb Samplesmentioning
confidence: 81%
See 4 more Smart Citations
“…This batch of (Mo) was selected and validated based on previous pharmacological and chemical studies using batches from four common suppliers (Baldwins (London, UK), Pranarom (Lille, France), Quinessence (Coalville, UK), Fytosan (Die, France); the composition correlates with the natural products Herbal Pharmacopoeia standards and was confirmed to be stable throughout the research programme (Dr Melanie-Jayne Howes, Jodrell Laboratory, Kew Gardens). Furthermore, a batch was selected and used in a parallel clinical trial in late-stage of Alzheimer's disease patients [18,19]. The GC-MS profile carried out at the Royal Botanic Garden at Kew (London), displayed no major changes in (Mo) composition following long-term storage (18 months) at 4°C in the dark (composition reported previously in [18,19]).…”
Section: Chemicals and Herb Samplesmentioning
confidence: 81%
“…Furthermore, a batch was selected and used in a parallel clinical trial in late-stage of Alzheimer's disease patients [18,19]. The GC-MS profile carried out at the Royal Botanic Garden at Kew (London), displayed no major changes in (Mo) composition following long-term storage (18 months) at 4°C in the dark (composition reported previously in [18,19]). Dilutions of essential oil stocks or components were performed fresh on the day of assay.…”
Section: Chemicals and Herb Samplesmentioning
confidence: 81%
See 3 more Smart Citations